A hypothesis for an embryonic origin of pluripotent Oct-4+ stem cells in adult bone marrow and other tissues

MZ Ratajczak, B Machalinski, W Wojakowski… - Leukemia, 2007 - nature.com
Accumulating evidence demonstrates that adult tissues contain a population of stem cells
that express early developmental markers such as stage-specific embryonic antigen and …

10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice

BE Strauer, G Steinhoff - Journal of the American College of Cardiology, 2011 - jacc.org
Intracoronary and intramyocardial stem cell therapy aim at the repair of compromised
myocardium thereby—as a causal treatment—preventing ventricular remodeling and …

Graphene oxide flakes as a cellular adhesive: prevention of reactive oxygen species mediated death of implanted cells for cardiac repair

J Park, B Kim, J Han, J Oh, S Park, S Ryu, S Jung… - ACS …, 2015 - ACS Publications
Mesenchymal stem cell (MSC) implantation has emerged as a potential therapy for
myocardial infarction (MI). However, the poor survival of MSCs implanted to treat MI has …

Stromal Cell–Derived Factor-1α Confers Protection Against Myocardial Ischemia/Reperfusion Injury: Role of the Cardiac Stromal Cell–Derived Factor-1α–CXCR4 Axis

X Hu, S Dai, WJ Wu, W Tan, X Zhu, J Mu, Y Guo… - Circulation, 2007 - Am Heart Assoc
Background—Stromal cell–derived factor-1α (SDF-1α) binding to its cognate receptor,
CXCR4, regulates a variety of cellular functions such as stem cell homing, trafficking, and …

Exosomes derived from adipose tissue, bone marrow, and umbilical cord blood for cardioprotection after myocardial infarction

H Xu, Z Wang, L Liu, B Zhang… - Journal of Cellular …, 2020 - Wiley Online Library
Human mesenchymal stem cells (MSCs) have the potential for improving cardiac function
following myocardial infarction (MI). This study was performed to explore the …

Graphene potentiates the myocardial repair efficacy of mesenchymal stem cells by stimulating the expression of angiogenic growth factors and gap junction protein

J Park, YS Kim, S Ryu, WS Kang, S Park… - Advanced Functional …, 2015 - Wiley Online Library
Stem cell therapy has emerged as a potential modality for myocardial infarction treatment.
Mesenchymal stem cells (MSCs) exert reparative actions in the injured myocardium mainly …

Perfusable branching microvessel bed for vascularization of engineered tissues

LLY Chiu, M Montgomery, Y Liang… - Proceedings of the …, 2012 - National Acad Sciences
Vascularization is critical for the survival of engineered tissues in vitro and in vivo. In vivo,
angiogenesis involves endothelial cell proliferation and sprouting followed by connection of …

[图书][B] Me medicine vs. we medicine: Reclaiming biotechnology for the common good

D Dickenson - 2013 - degruyter.com
I find it very interesting that the vaccine does the opposite of what its [sic] supposed to do. Is
any one open to the thought that this is intentional? That the people in power are using this …

Improvement of postnatal neovascularization by human embryonic stem cell–derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia

SW Cho, SH Moon, SH Lee, SW Kang, J Kim, JM Lim… - Circulation, 2007 - Am Heart Assoc
Background—We established an efficient preparation method to obtain endothelial-like cells
(ECs) from human embryonic stem cells (hESCs) and tested whether these hESC-ECs …

Endothelial progenitor cell-based neovascularization: implications for therapy

G Krenning, MJA van Luyn, MC Harmsen - Trends in molecular medicine, 2009 - cell.com
Ischemic cardiovascular events are a major cause of death globally. Endothelial progenitor
cell (EPC)-based approaches can result in improvement of vascular perfusion and might …